Vaxcyte, Inc.

Biological Products, (No Diagnostic Substances)·SAN CARLOS, CA·FY end 12/31·CIK 1649094

CEO Pay Ratio

48:1

Grant E. Pickering

CEO Total Comp

$14.5M

Grant E. Pickering

Median Employee

$303,873

Revenue

—

FY 2025

Net Income

-$766.6M

FY 2025

Free Cash Flow

-$669.3M

FY 2025

Net Margin

—

Insider Net (180d)

-$4.3M

0 buys / 24 sales

CEO Pay Accountability

CEO comp as % of net income

-1.89%

For every $1,000 of profit, $-18.86 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	—	—	—	—	—	—
Gross Profit	—	—	—	—	—	—
Operating Income	-$923.7M	-$569.5M	-$468.0M	-$232.3M	-$103.7M
Net Income	-$766.6M	-$463.9M	-$402.3M	-$223.5M	-$100.1M
Operating CF	-$655.6M	-$452.6M	-$296.8M	-$170.6M	-$121.4M
Capex	$13.7M	$22.4M	$16.1M	$5.8M	$6.6M
Free Cash Flow	-$669.3M	-$475.1M	-$312.9M	-$176.4M	-$127.9M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	—	—	—	—	—	—
Net Margin	—	—	—	—	—	—
FCF Margin	—	—	—	—	—	—
R&D / Revenue	—	—	—	—	—	—
Effective Tax	—	—	—	—	—	—
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Grant E. PickeringChief Executive Officer	$800.0K	$4.3M	$8.7M	$630.0K	$14.7K	$14.5M
Andrew GuggenhimePresident and Chief Financial Officer	$620.0K	$1.7M	$3.4M	$325.5K	$14.7K	$6.1M
Jim WassilExecutive Vice President and Chief Operating Officer	$600.0K	$1.9M	$3.3M	—	$14.7K	$5.8M
Mikhail EydelmanSenior Vice President, General Counsel and Corporate Secretary	$501.0K	$1.1M	$2.2M	$236.7K	$15.0K	$4.0M
Harp Dhaliwal	$495.0K	$998.2K	$2.0M	$233.9K	$14.7K	$3.8M